M. Kyle Cromer

University of California, San Francisco — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index2.2kcitations43works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(29), Virus-based gene therapy research(10), Pluripotent Stem Cells Research(6), Hemoglobinopathies and Related Disorders(5), Erythropoietin and Anemia Treatment(5)

Publications43 total

Novel humanized loss-of-function <i>NF1</i> mouse model of juvenile myelomonocytic leukemia
Blood Advances·2025· 1 citedOpen Access
S6363 Entangling Webs of Immunotherapy: A Case of Immune Checkpoint Inhibitor-Induced Gastritis
The American Journal of Gastroenterology·2025
Mobilization meets antibody conditioning: A path toward safer engraftment
Molecular Therapy·2025Open Access
Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells
Cell Reports Medicine·2025Open Access
Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells
STAR Protocols·2025Open Access
<i>In utero</i> lipid nanoparticle delivery achieves robust editing in hematopoietic stem cells
2025Open Access
UNCOVERseq Enables Sensitive and Controlled Gene Editing Off-Target Nomination Across CRISPR-Cas Modalities and Systems
2025· 2 citedOpen Access
Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus
Molecular Therapy — Methods & Clinical Development·2025· 2 citedOpen Access
Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis
Nature Communications·2025· 5 citedOpen Access
Dual α-globin-truncated erythropoietin receptor knockin restores hemoglobin production in α-thalassemia-derived erythroid cells
Cell Reports·2025· 6 citedOpen Access
Targeting the <i>JAK2-</i>V617F Mutation in Polycythemia Vera Using CRISPR/AAV6 Genome Editing
Blood·2024· 3 citedOpen Access
Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis
2024Open Access
Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells
Nature Biomedical Engineering·2024· 8 citedOpen Access
Engineering inducible signaling receptors to enable erythropoietin-free erythropoiesis
2024Open Access
Engineering inducible signaling receptors to enable erythropoietin-free erythropoiesis
2024Open Access
Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells
Developmental Cell·2024· 36 citedOpen Access
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells
Nature Communications·2024· 25 citedOpen Access
410.8: Improving the safety of stem-cell-derived beta cell transplantation with an inducible safety switch
Transplantation·2023Open Access
Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells
2023· 3 citedOpen Access
Using human genetics to develop strategies to increase erythropoietic output from genome-edited hematopoietic stem and progenitor cells
2023· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Matthew H. Porteus(27), Benjamin J. Lesch(13), Carsten T. Charlesworth(11), Joab Camarena(10), Daniel P. Dever(9), Christopher A. Vakulskas(8), Sridhar Selvaraj(8), Jessica P. Hampton(8), Kiran R. Majeti(8), Eric Soupène(8), Roshani Sinha(8), Rasmus O. Bak(7), Sofia E. Luna(7), Simon N. Chu(7), Devesh Sharma(7), Sriram Vaidyanathan(6), Freja K. Ekman(6), Travis McCreary(6), Mark A. Behlke(5), Mara Pavel-Dinu(5)